Tositumomab
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Tositumomab, covering 2010-08-02 to 2021-11-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma [Phase 2]